The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

UTHR FINANCIAL STATEMENTS

United Therapeutics Corporation — balance sheet, income statement and cash flow trends

UTHRUnited Therapeutics Corporation

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
01 B2 B3 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue3.2 B $Gross Profit2.7 B $ · 86%Operating Income1.4 B $ · 44%Pre-tax Income1.6 B $ · 50%Net Income to Owners1.3 B $ · 42%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue3.2 B $+2.5%
Gross Profit2.7 B $-0.8%
Operating Income1.4 B $-3.1%
EBITDA1.7 B $-3.7%
Net Income to Owners1.3 B $+5.5%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02.5 B5 B7.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets7.2 B
  • Equity6.4 B $89%
  • Current Liabilities607.8 M $8%
  • Long-term Liabilities212 M $3%

Key Figures

YoY change
Total Assets7.2 B $-8.7%
Total Liabilities819.8 M $+11.6%
Total Equity6.4 B $-10.8%
Cash & ST Investments2.7 B $-12.7%
Total Debt——
Net Debt-1.8 B $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0500 M1 B1.5 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
01 B2 B1.7 B $Operating744.5 M $Investing-2.2 B $Financing210.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow1.7 B $+22.9%
Capital Expenditures592.2 M $+97.2%
Free Cash Flow1.1 B $+2.1%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on UTHR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.